Latest Senior Health News

26Jul
2021

Major Medical Groups Call for Mandatory COVID Vaccination for Health Workers

Major Medical Groups Call for Mandatory COVID Vaccination for Health WorkersMONDAY, July 26, 2021 (HealthDay News) -- All health care workers should be required to be vaccinated against COVID-19, dozens of major U.S. medical groups said in a joint statement released Monday."Due to the recent COVID-19 surge and the availability of safe and effective vaccines, our health care organizations and societies advocate that all health care and long-term care employers require their workers to receive the COVID-19 vaccine," the statement said."This is the logical fulfillment of the ethical commitment of all health care workers to put patients, as well as residents of long-term care facilities, first and take all steps necessary to ensure their health and well-being," it said.The groups include the American Medical Association, American Academy of Pediatrics, American...

Cleaning Up the Air Could Help Prevent Alzheimer's

26 July 2021
Cleaning Up the Air Could Help Prevent Alzheimer`sMONDAY, July 26, 2021 (HealthDay News) -- Air pollution causes you to gasp and wheeze. Smog puts strain on your hearts and inflames your lungs.Could dirty air also be costing you your brain health?A trio of new studies finds that air quality appears linked to a risk of thinking declines and dementia, and bad air might even promote toxic brain proteins that are a hallmark of Alzheimer's disease."This is extremely exciting, because it indicates the potential that improving air quality levels could have on mortality levels, other areas of health, and also perhaps risk of dementia," said Claire Sexton, director of scientific programs and outreach for the Alzheimer's Association.In the first study, researchers found that reduction of fine particulate pollution and smog over a decade was...

Doctors Divided Over Use of Controversial New...

23 July 2021
Doctors Divided Over Use of Controversial New Alzheimer`s DrugFRIDAY, July 23, 2021 (HealthDay News) -- The controversial new Alzheimer's drug Aduhelm is creating something of a civil war in medicine, as health networks, hospitals, insurers and individual doctors weigh impending discussions with patients about whether they should take the medication.Many doctors believe the U.S. Food and Drug Administration "moved the goalposts" to approve Aduhelm (aducanumab) in early June, and they aren't inclined to recommend its use, said Dr. Ken Lin, a family physician with MedStar Georgetown University Hospital in Washington, D.C."I think a lot of primary care physicians are going to be reluctant to prescribe or to refer patients to have this prescribed, because I don't think we believe the quality of the data is there yet," Lin said in a HealthDay Now...

Drug Shows Promise in Easing Dementia-Linked Psychosis

23 July 2021
Drug Shows Promise in Easing Dementia-Linked PsychosisFRIDAY, July 23, 2021 (HealthDay News) -- A drug that eases hallucinations in people with Parkinson's disease may be able to do the same for those with dementia, a new clinical trial finds.The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and delusions related to Parkinson's.The new study, published July 22 in the New England Journal of Medicine, suggests the drug may help dementia patients plagued by those same symptoms.Researchers found that over 18 weeks, patients given Nuplazid were 65% less likely to see a resurgence of their hallucinations and delusions, compared to those on a placebo.The trial had been planned to run longer, but was stopped early when it became clear the drug was effective.Experts said the...

Drug Makers Reach $26 Billion Deal on Opioid Lawsuits

22 July 2021
Drug Makers Reach $26 Billion Deal on Opioid LawsuitsTHURSDAY, July 22, 2021 (HealthDay News) -- A proposed $26 billion settlement on opioid-related lawsuits has been reached with four large drug companies, a group of state attorneys general announced Wednesday.If enough states sign on to the deal with the country's three major drug distributors -- Cardinal Health, AmerisourceBergen and McKesson -- and pharmaceutical giant Johnson & Johnson, the companies could be released from all legal liability in the nation's opioid crisis that's killed hundreds of thousands of people, The New York Times reported.If states and cities accept the settlement that took two years to reach, they would drop thousands of lawsuits against the companies and promise not to launch any future legal action against them, the Times said. The money from the companies...
RSS
1345678910Last
HealthDay

Copyright © 2018 HealthDay. All rights reserved.